TEST:

Cxbladder

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)

@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPksAcw @UrolOncol @PacificEdgeLtd (@urotoday)

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)

From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)

@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPks2mY @UrolOncol @PacificEdgeLtd (@urotoday)

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)

From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)

@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPks2mY @UrolOncol @PacificEdgeLtd (@urotoday)

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)

From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLW9E (@urotoday)

If you manage patients with non muscle invasive bladder cancer, Cxbladder Monitor can help reduce the burden of surveillance cystoscopy. @SimaPorten and @DrJohnSfakianos join me to discuss their data and experience. https://t.co/tB63ExaqfT (@dshoskes)

From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()

“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()

"Kevin Li, Sima Porten et al on "Cxbladder Monitor Testing to Reduce Cystoscopy Frequency in Patients with Bladder Cancer" in @UrolOncol" @SimaPorten, @CChuMD, @Uro_Max Read more here: https://t.co/vlN96sF9V8 ()

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLW9E ()

Proud to share our findings on use of @Cxbladder Monitor during the #COVID19 pandemic to allow bladder cancer patients to skip in-person surveillance cystoscopy w/ negative test. Huge thanks to mentors @SimaPorten @CChuMD et al. for the support and guidance! ()

The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()

💥#MayoMGR today with @MarkTysonMD : "Hematuria – What is on the Horizon?" 💡Only 5% of #microhematuria pts have #bladdercancer➡️NPV of doing nothing is 95%! @MayoUrology @MayoMitch @Dr_Vijay_Shah #Hematuria #Cxbladder #Cystoscopy #UroTwitter #OncTwitter #MedTwitter ()

From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()

“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()

From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()

The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5leEy @UroOnc @SUO_YUO @PacificEdgeLtd ()

“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()